Bridging Data & Disparities: The Power of SDOH in the Life Sciences Industry

Image Credit: © iDoPixBox – stock.adobe.com A study recently published in JAMA Network Open compared response- and progression-based end points in clinical trials and clinical […]

ACT: How can feasibility studies be used to safeguard against trial complexities? Nambisan: So I touched on this just briefly in my prior response. But […]

ACT: Where do you think industry currently is with improving diversity in clinical trials? Saarony: It’s not where it needs to be. I say this […]